MoneyWorks4Me

Aurobindo Pharma informs about press release

22 Sep 2016 Evaluate

Aurobindo Pharma has informed about a Press Release dated September 22, 2016, titled ‘Aurobindo Pharma receives USFDA tentative approval for Dolutegravir, allowing the product to be launched in the Pepfar market’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1752.50
Dr. Reddys Labs. 1180.00
Cipla 1305.00
Lupin 1942.00
Zydus Lifesciences 1115.20
View more..